Leung, Louis
Pfizer (United States)
3 papers on CoChat
Most cited papers
- Verified
Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition
Telliez, J.-B., Dowty, M. E., Wang, L., Jussif, J., Lin, T., Li, L., Moy, E., Balbo, P., Li, W., Zhao, Y., et al. (2016) · ACS Chemical Biology
Cytokine Signaling Pathways and InteractionsPsoriasis: Treatment and Pathogenesis
Cited by 204
- Verified
Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2 S,5 R)-5-((7 H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans
Thorarensen, A., Dowty, M. E., Banker, M. E., Juba, B., Jussif, J., Lin, T., Vincent, F., Czerwinski, R. M., Casimiro-Garcia, A., Unwalla, R., et al. (2017) · Journal of Medicinal Chemistry
Cytokine Signaling Pathways and InteractionsHeterocyclic Compound Synthesis and Bioactivity
Cited by 176
- Verified
Setting Clinical Exposure Levels of Concern for Drug-Induced Liver Injury (DILI) Using Mechanistic in vitro Assays
Shah, F., Leung, L., Barton, H. A., Will, Y., Rodrigues, A. D., Greene, N., & Aleo, M. D. (2015) · Toxicological Sciences
Drug-Induced Hepatotoxicity and ProtectionAnimal testing and alternatives
Cited by 148
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free